Nu-Med Plus (NUMD) Depreciation & Amortization (IS) (2013 - 2022)

Nu-Med Plus' (NUMD) quarterly Depreciation & Amortization (IS) came in at $34.0 in Q3 2022, down 98.72% year-on-year from $2649.0 in Q3 2021, and down 84.33% quarter-over-quarter from $217.0 in Q2 2022.

Nu-Med Plus (NUMD) Depreciation & Amortization (IS) (2013 - 2022) Analysis & Trends

Nu-Med Plus has disclosed Depreciation & Amortization (IS) across 5 years of filings, most recently posting $34.0 for Q3 2022.

  • Depreciation & Amortization (IS) for Q3 2022 came in at $34.0, down 98.72% year-over-year; the trailing twelve-month figure through Dec 2022 was $2266.0 (down 73.14% YoY), and the FY2022 annual result was $2267.0, down 75.79% from the prior year.
  • Depreciation & Amortization (IS) came in at $34.0 for Q3 2022 at Nu-Med Plus, down from $217.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $2650.0 in Q4 2021 to a low of $34.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 310.25 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Nu-Med Plus - - - -

Historic Data

Download Data
DateValue
Sep 30, 2022 34.00
Jun 30, 2022 217.00
Mar 31, 2022 2,015.00
Dec 31, 2021 2,650.00
Sep 30, 2021 2,649.00
Jun 30, 2021 1,417.00
Dec 31, 2015 1,720.00
Sep 30, 2015 1,855.00
Jun 30, 2015 1,787.00
Mar 31, 2015 1,786.00
Dec 31, 2014 1,768.00
Sep 30, 2014 1,732.00
Jun 30, 2014 1,732.00
Mar 31, 2014 1,732.00
Dec 31, 2013 1,053.00
Sep 30, 2013 744.00
Jun 30, 2013 699.00
Mar 31, 2013 699.00